Overview
The goal of this clinical trial]is to evaluate if learning to play traditional board games could improve cognition in subjects with mild cognitive impairment and subjective cognitive decline. The main questions it aims to answer are:
- Do Go and Chess improve cognition?
- Is a game better than the other? Is the effect of both games on cognition synergistic?
- Do Go and Chess improve quality of life?
- Do Go and Chess improve mood?
- Do Go and Chess improve lifestyle?
Participants will be randomized to one of four groups:
- Group intervention with Go, once a week, for 12 weeks
- Group intervention with Chess, once a week, for 12 weeks
- Group intervention with Go and Chess, twice a week, for 12 weeks
- Control group
Eligibility
Inclusion Criteria:
- Diagnosis of mild cognitive impairment or subjective cognitive decline
- Willingness to participate in the board games classes
- Living within 20-minute driving distance from the center
- Signed informed consent
Exclusion Criteria:
- Prior knowledge of the the game rules (in case the subject knows one of the two, they can be randomized to the other one)
- Significant linguistic or sensory impairment (according to clinical judgment)
- Significant behavioral or psychiatric disturbances (according to clinical judgment)
- Significant medical comorbidities (according to clinical judgment)